Why Genezen? We’re a focused company dedicated to exceptional gene and cell therapy. When you’re ready to start or shift your development journey, our team offers the guidance, expertise, technology, and manufacturing capacity to help bring your viral vector therapy to patients with accuracy and speed.
Making viral vector production accessible, we act with care to realize the immense potential of your products.
Client-centric guidance paired with complete development capabilities and manufacturing capacity, we can provide tailored solutions and help you overcome challenges and accelerate your therapy’s development.
Leverage our specialist expertise and powerful network of academic and research partners. Founded to connect biotech and academia, we have collaboration in our DNA.
Lentiviral vectors are an innovative area in cell therapy and are one of the more challenging and complex viral vectors to develop and manufacture. We have unique knowledge and technical talent within our team.
Our entrepreneurial spirit and experience are backed by the financial investment of Ampersand Capital Partners, securing the resources and action plan to support our clients from concept to commercialization.
We focus on quality to advance your product through clinical milestones as quickly and safely as possible.Read more
We have the capacity, technologies and experience to accelerate your cell and gene therapy development success.Read more
Our team is dedicated to getting your viral vector where it needs to go. Communication and collaboration are part of our DNA and we can't wait to talk to you about your current challenges and needs.